Text Size: S M L

Home > What's New for Physicians

FDA APPROVES VENTRICULAR ASSIST DEVICE FOR PERMANENT USE The FDA approved the use of the HeartMate II device, a left ventricular assist device (VAD), for "destination therapy" or permanent use, allowing an alternative to heart transplant for end-stage heart-failure patients and helping patients survive long term.

VACCINE TRIAL AGAINST RECURRENT LUNG CANCER IN OPEN ENROLLMENT Patient enrollment is open for clinical trials for the MAGE-A3-based vaccine answers a need for a highly efficient and safe therapy for patients who have undergone conventional treatment for a primary tumor but are at a high risk of relapse.